Search Results

Findings support use of gemcitabine/docetaxel as alternative to BCG.

• Authors : CLARKE, HANNAH

Subjects: BLADDER tumors; GENERIC drug substitution; GEMCITABINE

• Source: Urology Times. Sep2023, Vol. 51 Issue 9, p13-13. 1/2p.

Record details

TAR-200 may bolster NMIBC treatment options.

Subjects: NON-muscle invasive bladder cancer; INTRAVESICAL administration; MEDICAL technology

• Source: Urology Times. Mar2024, Vol. 52 Issue 3, p18-20. 3p.

Record details

Gemcitabine/docetaxel for NMIBC appears safe and efficacious.

• Authors : MIAN, BADAR M.

Subjects: DRUG efficacy; INTRAVESICAL administration; GEMCITABINE

• Source: Urology Times. May2023, Vol. 51 Issue 5, p17-17. 1p.

Record details

Management of BCG-unresponsive NMIBC.

• Authors : Passarelli, Rachel; Packiam, Vignesh T.

Subjects: BLADDER tumors; DISEASE progression; CYSTECTOMY

• Source: Urology Times. Feb2024, Vol. 52 Issue 2, p20-21. 2p.

Record details

Sequential gemcitabine and docetaxel proves efficacious in NMIBC.

• Authors : Guttman Krader, Cheryl

Subjects: THERAPEUTIC use of antimetabolites; ANTIMETABOLITES; ANTINEOPLASTIC agents

• Source: Urology Times. Aug2020, Vol. 48 Issue 8, p1-11. 2p.

Record details

Gemcitabine Injection.

• Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Sequential gemcitabine and docetaxel proves efficacious in NMIBC: Intravesical instillations prevent recurrence of non-muscle-invasive bladder cancer.

• Authors : Guttman Krader, Cheryl

Subjects: THERAPEUTIC use of antimetabolites; ANTIMETABOLITES; BCG vaccines

• Source: Urology Times. Aug2020, Vol. 48 Issue 8, p11-11. 1p.

Record details

Chemo/RT regimens provide bladder-sparing options in bladder Ca: Gemcitabine-, cisplatin-based treatments both met prespecified DMF3 benchmark.

• Authors : Levitan, Dave

Subjects: CISPLATIN; THERAPEUTIC use of antimetabolites; ADJUVANT treatment of cancer

• Source: Urology Times. Apr2019, Vol. 47 Issue 4, p11-11. 3/4p.

Record details

Gemcitabine may be effective in treating advanced PCa.

• Authors : Bowser, Andrew

Subjects: PROSTATE cancer treatment; ANTINEOPLASTIC agents; DRUG efficacy

• Source: Urology Times. May98, Vol. 26 Issue 5, p12. 2p.

Record details

Sequential gemcitabine/docetaxel promising for recurrent NMIBC: Regimen could be alternative strategy for BCG-unresponsive patients.

• Authors : MIAN, BADAR M.

Subjects: ANTINEOPLASTIC agents; BCG immunotherapy; THERAPEUTIC use of antimetabolites

• Source: Urology Times. Mar2020, Vol. 48 Issue 3, p38-39. 2p.

Record details